Intervention

Iguratimod

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting1
Common conditions4
Lead sponsors shown5

Clinical trials

10 shown
The Clinical Efficacy of Immunomodulators in RA PatientsNCT05626348 · 2021-12-22
RECRUITING
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid ArthritisNCT06146972 · 2021-06-01
UNKNOWN
The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RANCT04928066 · 2020-03-01
COMPLETED
Study of Iguratimod in Sjögren's SyndromeNCT03023592 · 2017-02-01
UNKNOWN
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months TreatmentNCT03855007 · 2016-01-01
COMPLETED
Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid ArthritisNCT02275299 · 2013-09-01
UNKNOWN
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid ArthritisNCT01850966 · 2012-09-12
COMPLETED
Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRINCT01893151 · 2012-07-01
UNKNOWN
A Study of Iguratimod in Patients With Active Rheumatoid ArthritisNCT01554917 · 2012-05-01
COMPLETED
Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid ArthritisNCT01548001 · 2012-05-01
UNKNOWN

Trial status mix

UNKNOWN5
COMPLETED4
RECRUITING1

Phase mix

PHASE48
PHASE11
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.